Jyothy Labs Limited (JYOTHYLAB.BO)
INR 392.05
(-0.48%)
INR 392.05
(-0.48%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 5.9 Billion INR | 15.68% |
| 2022 | 5.1 Billion INR | -17.62% |
| 2021 | 6.19 Billion INR | 9.66% |
| 2020 | 5.65 Billion INR | -11.21% |
| 2019 | 6.36 Billion INR | -0.08% |
| 2018 | 6.37 Billion INR | -24.92% |
| 2017 | 8.48 Billion INR | 10.11% |
| 2016 | 7.7 Billion INR | -11.49% |
| 2015 | 8.7 Billion INR | 2.52% |
| 2014 | 8.49 Billion INR | -7.44% |
| 2013 | 9.17 Billion INR | 4.9% |
| 2012 | 8.74 Billion INR | 9.31% |
| 2011 | 8 Billion INR | 299.2% |
| 2010 | 2 Billion INR | 32.63% |
| 2009 | 1.51 Billion INR | 0.0% |
| 2007 | 677.97 Million INR | 37.53% |
| 2006 | 492.95 Million INR | 40.99% |
| 2005 | 349.63 Million INR | 18.52% |
| 2004 | 295 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 5.9 Billion INR | 15.68% |
| 2023 Q2 | 5.78 Billion INR | 0.0% |
| 2023 Q4 | 5.9 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q4 | 5.1 Billion INR | 0.0% |
| 2022 Q2 | 6.36 Billion INR | 0.0% |
| 2022 FY | 5.1 Billion INR | -17.62% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 6.19 Billion INR | 9.66% |
| 2021 Q2 | 5.68 Billion INR | 0.0% |
| 2021 Q4 | 6.19 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q4 | 5.65 Billion INR | 0.0% |
| 2020 FY | 5.65 Billion INR | -11.21% |
| 2020 Q2 | 6.09 Billion INR | 0.0% |
| 2019 Q4 | 6.36 Billion INR | 0.0% |
| 2019 FY | 6.36 Billion INR | -0.08% |
| 2019 Q2 | 7.2 Billion INR | 0.0% |
| 2018 FY | 6.37 Billion INR | -24.92% |
| 2018 Q4 | 6.37 Billion INR | 0.0% |
| 2017 FY | 8.48 Billion INR | 10.11% |
| 2017 Q4 | 8.48 Billion INR | 0.0% |
| 2017 Q2 | 8.87 Billion INR | 0.0% |
| 2016 Q2 | 9.31 Billion INR | 0.0% |
| 2016 FY | 7.7 Billion INR | -11.49% |
| 2016 Q4 | 7.7 Billion INR | 0.0% |
| 2015 Q4 | 8.7 Billion INR | 0.0% |
| 2015 FY | 8.7 Billion INR | 2.52% |
| 2015 Q2 | 8.99 Billion INR | 0.0% |
| 2014 Q4 | 8.49 Billion INR | 0.0% |
| 2014 FY | 8.49 Billion INR | -7.44% |
| 2014 Q2 | 8.71 Billion INR | 0.0% |
| 2013 FY | 9.17 Billion INR | 4.9% |
| 2013 Q4 | 9.17 Billion INR | 0.0% |
| 2012 FY | 8.74 Billion INR | 9.31% |
| 2011 FY | 8 Billion INR | 299.2% |
| 2010 FY | 2 Billion INR | 32.63% |
| 2009 FY | 1.51 Billion INR | 0.0% |
| 2007 FY | 677.97 Million INR | 37.53% |
| 2006 FY | 492.95 Million INR | 40.99% |
| 2005 FY | 349.63 Million INR | 18.52% |
| 2004 FY | 295 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Ador Multiproducts Limited | 28.52 Million INR | -20606.674% |
| Ambica Agarbathies Aroma & Industries Limited | 1.09 Billion INR | -437.115% |
| Bajaj Consumer Care Limited | 1.53 Billion INR | -286.089% |
| Colgate-Palmolive (India) Limited | 13.22 Billion INR | 55.322% |
| Cupid Limited | 186.52 Million INR | -3066.958% |
| Dabur India Limited | 48.19 Billion INR | 87.743% |
| Emami Limited | 8.21 Billion INR | 28.135% |
| Gillette India Limited | 8.59 Billion INR | 31.27% |
| Godrej Consumer Products Limited | 58.97 Billion INR | 89.983% |
| Hindustan Unilever Limited | 270.76 Billion INR | 97.818% |
| Hipolin Limited | 48.57 Million INR | -12061.489% |
| Honasa Consumer Limited | 5.36 Billion INR | -10.05% |
| JHS Svendgaard Laboratories Limited | 271.7 Million INR | -2074.115% |
| Kaya Limited | 5.22 Billion INR | -13.113% |
| Marico Limited | 32.52 Billion INR | 81.835% |
| N.K Industries Limited | 22.4 Billion INR | 73.632% |
| PAOS INDUSTRIES LIMITED | 163.96 Million INR | -3502.632% |
| Paramount Cosmetics (India) Limited | 205.72 Million INR | -2771.406% |
| Pee Cee Cosma Sope Limited | 80.17 Million INR | -7267.515% |
| Procter & Gamble Hygiene and Health Care Limited | 10.83 Billion INR | 45.49% |